Kathleen A. Dorritie, MD

Kathleen Dorritie, MD, a hematologist and medical oncologist at UPMC CancerCenter
  • Specialty:

    Internal Medicine
  • Secondary Specialty:

    Medical Oncology Hematology
  • Board Certifications:

    Hematology, Internal Medicine, Medical Oncology
  • Education:

    MD, SUNY Upstate Medical University, Syracuse, NY
  • Residency:

    University of Pittsburgh School of Medicine, Pittsburgh, PA
  • Fellowships:

    University of Pittsburgh School of Medicine, Pittsburgh, PA
  • Affiliations:

    UPMC Magee-Womens Hospital UPMC Presbyterian UPMC Shadyside


Kathleen Dorritie, MD, is a hematologist/medical oncologist at UPMC Hillman Cancer Center specializing in hematologic malignancies and stem cell transplantation. Her research focuses on early phase clinical trials for lymphoid malignancies. She has been very involved in the development of the CAR T-cell program at UPMC and has also worked to develop a stem cell transplant program for hemoglobinopathies, including sickle cell disease.

Dr. Dorritie is board-certified in internal medicine, medical oncology, and hematology. She received her medical degree at State University of New York Upstate Medical University, Syracuse, N.Y. Dr. Dorritie completed her residency in internal medicine and her hematology/oncology fellowship at UPMC.

Dr. Dorritie is a member of The American Society of Hematology, the American Society for Blood and Marrow Transplantation, the American Society of Clinical Oncology, and the American Association for Cancer Research.